Article

Poor, uninsured most likely to see poorly

Individuals who are visually impaired are more likely to be in a lower socioeconomic bracket in the United States, not to have private insurance, and to have an eye disease that is undetected.

Los Angeles-Individuals who are visually impaired are more likely to be in a lower socioeconomic bracket in the United States, not to have private insurance, and to have an eye disease that is undetected. Visually impaired persons who are of working age suffer the greatest economic impact because of their disability, said Rohit Varma, MD, MPH.

The survey also showed that the economic impact of visual impairment is greatest among individuals in the younger age groups, those who are of working age, Dr. Varma said.

Visually impaired individuals are less likely to have private insurance. They are more likely to be receiving Medicare or Medicaid benefits.

Regarding employment, the same type of pattern emerges in the national survey. These individuals are less likely to be employed.

"Almost one-third of those who are visually impaired believe that they are prevented from working as a result of their impairment," he said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.